Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.29 | 2e-17 |
mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.23 | 6e-12 |
mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-09 |
mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.19 | 6e-08 |
mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.17 | 5e-06 |
mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |
mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-05 |
mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.13 | 4e-05 |
mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.0001 |
mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0002 |